MOTIXAFORTIDE

UNII:	DA9G065962
Type:	INGREDIENT SUBSTANCE
Formula:	C₉₇H₁₄₄FN₃₃O₁₉S₂
Preferred Substance Name:	MOTIXAFORTIDE
InChIKey:	JJVZSYKFCOBILL-MKMRYRNGSA-N
GSRS Full Record:	DA9G065962 i

664334-36-5
(3S,6S,9S,12S,15R,20R,23S,26S,29S,32S)-3,6-bis(4-aminobutyl)-N-[(2S)-1-amino-5-carbamimidamido-1-oxopentan-2-yl]-15-[[(2S)-2-[[(2S)-5-carbamimidamido-2-[[(2S)-5-carbamimidamido-2-[(4-fluorobenzoyl)amino]pentanoyl]amino]pentanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]-26-(3-carbamimidamidopropyl)-9,23-bis[3-(carbamoylamino)propyl]-12,29-bis[(4-hydroxyphenyl)methyl]-2,5,8,11,14,22,25,28,31-nonaoxo-17,18-dithia-1,4,7,10,13,21,24,27,30-nonazabicyclo[30.3.0]pentatriacontane-20-carboxamide
4F-BENZOYL-TN-14003
BKT-140
BKT140
BL-8040
L-ARGININAMIDE, N2-(4-FLUOROBENZOYL)-L-ARGINYL-L-ARGINYL-3-(2-NAPHTHALENYL)-L-ALANYL-L-CYSTEINYL-L-TYROSYL-N5-(AMINOCARBONYL)-L-ORNITHYL-L-LYSYL-D-LYSYL-L-PROLYL-L-TYROSYL-L-ARGINYL-N5-(AMINOCARBONYL)-L-ORNITHYL-L-CYSTEINYL-, CYCLIC (4->13)-DISULFIDE
MOTIXAFORTIDE [USAN]
Motixafortide [WHO-DD]
N-(4-FLUORO-BENZOYL)-L-ARGINYL-L-ARGINYL-(L-3-(NAPHTHYL)ALANYL)-L-CYSTEINYL-L-TYROSYL-L-CITRULLINYL-L-LYSYL-D-LYSYL-L-PROLYL-L-TYROSYL-L-ARGINYL-L-CITRULLINYL-L-CYSTEINYL-L-ARGININE AMIDE,CYCLIC (4-13)-DISULFIDE
S3.4,S3.13-CYCLO(N.ALPHA.-(4-FLUOROBENZOYL)-L-ARGINYL-L-ARGINYL-3-(NAPHTHALEN-2-YL)-L-ALANYL-L-CYSTEINYL-L-TYROSYL-N5-CARBAMOYL-L-ORNITHYL-L-LYSYL-D-LYSYL-L-PROLYL-L-TYROSYL-LARGINYL-N5-CARBAMOYL-L-ORNITHYL-L-CYSTEINYL-L-ARGININAMIDE)
T140
TF-14016
motixafortide [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

MOTIXAFORTIDE

Synonyms and Mappings

Resources